The National Cancer Institute (NCI) and its designated Comprehensive Cancer Centers have made "translational research" a major focus.
NCI defines translational research in terms of transforming scientific discoveries made in laboratory, clinical or population-based research into clinical applications that can reduce the cancer burden.
At Chao Family Comprehensive Cancer Center, Orange County's only NCI-designated comprehensive cancer center, our translational research efforts are focused on four areas of strength: skin, prostate, colon and women's cancers. Our extremely active and productive clinical working groups in these four areas are composed of basic scientists, epidemiologists and clinicians who have a keen interest in moving their ideas and discoveries into new treatments and interventions to help our cancer patients.
Developing Tomorrow's Cancer Therapies and Treatments
Each clinical working group is committed to developing new treatments and interventions to help cancer patients. To do this, the cancer center has established multidisciplinary teams whose purpose is to transform their ideas and discoveries into clinical trials and funded research programs to progress and develop new therapies for cancer.
Disease-Oriented Teams (DOTs)